- Home
- KALU vs QDEL Comparison
KALU vs QDEL Comparison
Compare KALU & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KALU | QDEL |
|---|---|---|
| Founded | 1946 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 1991 | N/A |
Fundamental Metrics
Financial Performance| Metric | KALU | QDEL |
|---|---|---|
| Price | $144.51 | $28.38 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | ★ $99.67 | $40.00 |
| AVG Volume (30 Days) | 184.2K | ★ 1.0M |
| Earning Date | 02-18-2026 | 02-11-2026 |
| Dividend Yield | ★ 2.20% | N/A |
| EPS Growth | ★ 58.01 | N/A |
| EPS | ★ 5.17 | N/A |
| Revenue | ★ $3,209,400,000.00 | $2,714,400,000.00 |
| Revenue This Year | $12.86 | N/A |
| Revenue Next Year | $13.04 | $2.28 |
| P/E Ratio | $27.10 | ★ N/A |
| Revenue Growth | ★ 7.69 | N/A |
| 52 Week Low | $46.81 | $19.50 |
| 52 Week High | $144.93 | $43.92 |
Technical Indicators
Market Signals| Indicator | KALU | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 66.25 | 45.83 |
| Support Level | $138.92 | $27.75 |
| Resistance Level | $144.93 | $30.50 |
| Average True Range (ATR) | 6.16 | 1.50 |
| MACD | 0.89 | -0.03 |
| Stochastic Oscillator | 95.32 | 56.50 |
Price Performance
Historical ComparisonAbout KALU Kaiser Aluminum Corporation
Kaiser Aluminum Corp produces and sells semi-fabricated specialty aluminum products predominantly to industrial customers. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.